LCP: Assay, Glycosylated Hemoglobin
What it covers
A glycosylated hemoglobin assay is a device used to measure the glycosylated hemoglobins (A1a, A1b, and A1c) in a patient's blood by a column chromatographic procedure. Measurement of glycosylated hemoglobin is used to assess the level of control of a patient's diabetes and to determine the proper insulin dosage for a patient. Elevated levels of glycosylated hemoglobin indicate uncontrolled diabetes in a patient.
The identification in 21 CFR 864.7470, glycosylated hemoglobin assay. FDA gives LCP no definition of its own, so the regulation’s describes it.
Recent clearances
| 510(k) | Device | Applicant | Decision | Type |
|---|---|---|---|---|
| K221326 | Nova Allegro HbA1c Assay, Nova Allegro Analyzer | Nova Biomedical Corporation | Nov 22, 2024 | Dual Track |
| K231465 | Q-Pad Test System | Qurasense | Dec 6, 2023 | Traditional |
| K214117 | Afinion HbA1c, Afinion 2 and Alere Afinion AS100 Analyzer | Abbott Diagnostics Technologies AS | Sep 27, 2023 | Dual Track |
| K192987 | Aina HbA1c Monitoring System 2 | Jana Care, Inc. | Mar 26, 2020 | Traditional |
| K192369 | PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test Kit | Ixensor Co, Ltd. | Oct 29, 2019 | Traditional |
| K183230 | OneDraw A1C Test System | Drawbridge Health, Inc. | Aug 15, 2019 | Traditional |
| K181915 | PixoTest POCT System - PixoTest POCT Analyzer and PixoTest A1c Test Kit | Ixensor Co, Ltd. | Apr 12, 2019 | Traditional |
| K180509 | Quo-Test A1c System | Ekf-Diagnostic GmbH | Feb 16, 2019 | Dual Track |
| K173127 | skyla Hi Hemoglobin A1c System (skyla Hi Analyzer and skyla Hi Hemoglobin A 1 c Reagent Kit) | Skyla Corporation H.S.P.B | Sep 25, 2018 | Traditional |
| K170623 | ACE Hemoglobin A1c (HbA1c) Reagent | Alfa Wassermann Diagnostic Technologies, LLC | Feb 27, 2018 | Traditional |
Clearances by year
49 LCP 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.
| Year | Clearances | Median days to decision |
|---|---|---|
| 2024 | 1 | 931 |
| 2023 | 2 | 419 |
| 2020 | 1 | 153 |
| 2019 | 4 | 269 |
| 2018 | 2 | 362 |
| 2017 | 5 | 218 |
| 2016 | 2 | 372 |
| 2015 | 3 | 239 |
| 2014 | 8 | 127 |
| 2013 | 2 | 29 |
| 2012 | 9 | 143 |
| 2011 | 10 | 176 |
Who submits
37 applicants cleared a LCP device since 2011. 73% of the clearances went to applicants in United States, then Taiwan (8%), Norway (6%) and Japan (4%). By type: Traditional 73%, Special 20% and Dual Track 6%.
| Applicant | Clearances since 2011 |
|---|---|
| Beckman Coulter, Inc. | 3 |
| Bio-Rad Laboratories, Inc., Clinical Systems Divis | 3 |
| Diazyme Laboratories | 3 |
| Sebia | 3 |
| Infopia Co, Ltd. | 2 |
| Ixensor Co, Ltd. | 2 |
| Sakae Corporation | 2 |
| Siemens Healthcare Diagnostics | 2 |
How FDA classifies it
Class II (performance standards).
From 21 CFR 864.7470.
Standards
21 CFR 864.7470 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent LCP clearances declared.
Ask about LCP
Questions about LCP
What is FDA product code LCP?
Product code LCP, “Assay, Glycosylated Hemoglobin” in FDA's classification database, is a Class II device type under 21 CFR 864.7470 (glycosylated hemoglobin assay), reviewed by FDA's Hematology panel. FDA's 510(k) database lists 249 clearances under LCP, 49 of them since 2011.
How many 510(k) clearances are there under LCP?
FDA’s 510(k) database listed 249 clearances under LCP as of Oct 29, 2026, 49 of them decided since 2011; the most recent decision was Nov 22, 2024. The Predicate Finder searches the live database.
How long does FDA take to clear a LCP 510(k)?
For the 1 LCP clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 931 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.
Which companies have the most LCP clearances?
Since 2011: Beckman Coulter, Inc. (3), Bio-Rad Laboratories, Inc., Clinical Systems Divis (3), Diazyme Laboratories (3), Sebia (3) and Infopia Co, Ltd. (2). 37 applicants have cleared a LCP device in that time.